Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 8.28 is 25% below its 5-year average of 11.02, around the middle of its 5-year range (1.50–18.97).
As of the fiscal period ended Tuesday, June 30, 2026. 0.16% below its 12-month average of 8.29.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 8.28.
CURRENT RATIO
8.28
CURRENT RATIO AVG TTM
8.29
CURRENT RATIO AVG 3Y
9.45
CURRENT RATIO AVG 5Y
11.02
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-0.16%
CURRENT VS 3Y AVG
-12.42%
CURRENT VS 5Y AVG
-24.86%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.59
median of 758 covered companies
CURRENT VS SECTOR MEDIAN
+130.33%
vs the sector median at left
Century Therapeutics, Inc.
Market Cap
$251.69M
Current Ratio
8.28
TTM Avg
8.29
3Y Avg
9.45
5Y Avg
11.02
Market Cap
$250.99M
Current Ratio
10.37
TTM Avg
5.14
3Y Avg
8.08
5Y Avg
7.69
Market Cap
$246.29M
Current Ratio
9.97
TTM Avg
9.81
3Y Avg
16.34
5Y Avg
20.09
Market Cap
$258.43M
Current Ratio
4.48
TTM Avg
4.80
3Y Avg
5.23
5Y Avg
5.23
Market Cap
$244.33M
Current Ratio
10.14
TTM Avg
15.36
3Y Avg
19.42
5Y Avg
27.25
Market Cap
$243.62M
Current Ratio
3.87
TTM Avg
3.17
3Y Avg
2.70
5Y Avg
2.15
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Century Therapeutics, Inc. (IPSC) | $251.69M | 8.28 | 8.29 | 9.45 | 11.02 |
| Sol-Gel Technologies Ltd. (SLGL)vs › | $250.99M | 10.37 | 5.14 | 8.08 | 7.69 |
| AC Immune S.A. (ACIU)vs › | $261.05M | 0.93 | 1.36 | 5.78 | 8.29 |
| Quantum-Si incorporated (QSI)vs › | $246.29M | 9.97 | 9.81 | 16.34 | 20.09 |
| Q32 Bio Inc. (QTTB)vs › | $246.15M | 20.30 | 4.91 | 4.89 | 6.73 |
| Anika Therapeutics, Inc. (ANIK)vs › | $258.43M | 4.48 | 4.80 | 5.23 | 5.23 |
| Invivyd, Inc. (IVVD)vs › | $244.52M | 5.87 | 4.43 | 7.10 | 7.89 |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $244.33M | 10.14 | 15.36 | 19.42 | 27.25 |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.62M | 3.87 | 3.17 | 2.70 | 2.15 |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $242.34M | 1.54 | 1.17 | 19.33 | 29.22 |
Current Ratio
8.28
Quick Ratio
8.28
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 8.28 |
| 2026-03-31 | 10.25 |
| 2025-12-31 | 5.97 |
| 2025-09-30 | 6.25 |
| 2025-06-30 | 10.72 |
| 2025-03-31 | 11.70 |
| 2024-12-31 | 1.50 |
| 2024-09-30 | 10.39 |
| 2024-06-30 | 10.62 |
| 2024-03-31 | 12.44 |
| 2023-12-31 | 9.92 |
| 2023-09-30 | 8.50 |
| 2023-06-30 | 8.42 |
| 2023-03-31 | 9.24 |
| 2022-12-31 | 10.72 |
| 2022-09-30 | 13.44 |
| 2022-06-30 | 17.79 |
| 2022-03-31 | 16.62 |
| 2021-12-31 | 14.57 |
| 2021-09-30 | 15.12 |
| 2021-06-30 | 18.97 |
| 2021-03-31 | 14.35 |
| 2020-12-31 | 6.51 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
